WLK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. WLK is sitting on key support (79.09) with bearish momentum (MACD histogram negatively expanding) and very bearish options flow (extreme put-volume dominance), alongside heavy insider selling. While the stock looks short-term oversold and has upside if support holds, the current tape and sentiment do not favor an impatient entry. I would avoid buying until price stabilizes and reclaims the pivot area (83.78) or until after the upcoming earnings event clarifies fundamentals.
Trend/momentum: Bearish near-term. The MACD histogram is -1.053 and expanding negatively, signaling increasing downside momentum. RSI_6 at 28.37 suggests short-term oversold conditions (potential for a bounce), but oversold alone is not a buy signal when momentum is still deteriorating.
Levels: Price 79.32 is essentially on S1 support (79.091). A clean break below S1 increases odds of a move toward S2 (76.195). Upside resistance starts at the pivot (83.778), then R1 (88.465).
Moving averages: Converging MAs suggest a transition/indecision phase, but with MACD bearish, the path of least resistance remains down until a base forms.
Intellectia Proprietary Trading Signals: No strong systematic buy trigger today.
on 2026-02-23 pre-market can reset expectations if results/guide improve versus depressed sentiment.
Options market is signaling downside concern: extreme put-volume dominance plus high IV percentile suggests traders are positioned for further weakness.
Latest reported quarter: 2025/Q3. Growth and profitability deteriorated sharply.
Recent trend: Overall still constructive, with a notable re-acceleration in bullish price targets in January 2026 (Truist $99, RBC $100, both Buy/Outperform; Mizuho raised to $88). However, late-2025 saw meaningful cuts (Morgan Stanley to $80; Citi to $75; Alembic to $80), reflecting spread compression, feedstock costs, and slow construction. Wall Street pros: (1) visibility into 2026–27 earnings uplift from cost reductions/restructuring, (2) strong balance sheet/low leverage enabling flexibility, (3) leverage to a construction recovery. Wall Street cons: (1) commodity chemical oversupply/spread pressure, (2) weak near-term earnings expectations and input-cost headwinds, (3) cyclicality driving large profit swings (consistent with the Q3 loss).
